Design, Synthesis, and Biological Evaluation of Newer Arylidene Incorporated 4-Thiazolidinones Derivatives as Potential Antimicrobial Agents

References

• I. Ahmad, and A. Z. Beg, “Antimicrobial and Phytochemical Studies on 45 Indian Medicinal Plants against Multi-Drug Resistant Human Pathogens,” Journal of Ethnopharmacology 74, no. 2 (2001): 113–23.
   PubMed Web of Science ®Google Scholar
• S. Ningaiah, U. K. Bhadraiah, S. Keshavamurthy, and C. Javarasetty, “Novel Pyrazoline Amidoxime and Their 1,2,4-Oxadiazole Analogues: synthesis and Pharmacological Screening,” Bioorganic & Medicinal Chemistry Letters 23, no. 16 (2013): 4532–9.
   PubMed Web of Science ®Google Scholar
• T. A. J. Vincent, “Current and future antifungal therapy: new targets for antifungal agents,” Antimicrob Chemother 44, (1999): 151–162.
   Google Scholar
• (a) K. M. Amin, D. E. Rahman, and Y. A. Al-Eryani, “Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents,” Bioorg. Med. Chem. 16, (2008): 5377–88;
   PubMed Web of Science ®Google Scholar
  (b) M. L. Barreca, A. Chimirri, L. De Luca, A. M. Monforte, P. Monforte, A. Rao, M. Zappala, J. Balzarini, E. De Clercq, C. Pannecouque, and M. Witvrouw, “Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents,” Bioorg. Med. Chem. Lett. 11, (2001): 1793–96;
   PubMed Web of Science ®Google Scholar
  (c) A. M. Shawky, M. A. S. Abourehab, A. N. Abdalla, and A. M. Gouda, “Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency,” Eur. Jour. of Med. Chem. 185, (2020): 111780;
   PubMed Web of Science ®Google Scholar
  (d) S. V. Bhandari, K. G. Bothara, A. A. Patil, T. S. Chitre, A. P. Sarkate, S. T. Gore, S. C. Dangre, and C. V. Khachane, “Design, Synthesis and Pharmacological Screening of Novel Antihypertensive Agents Using Hybrid Approach,” Bioorg. Med. Chem. 17, (2009): 390–400;
   PubMed Web of Science ®Google Scholar
  (e) M. J. Joy, N. Jacob, and N. G. Kutty, “Evaluation of hypoglycemic effects of 4-thiazolidinones” Indian Drugs, 42, (2005): 17–21;
   Google Scholar
  (f) Bhutani R., D. P. Pathak, Kapoor G., Husain A., and Iqbal Md. A., “Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment,” Bioorg. Chem. 83, (2019): 6–19;
   PubMed Web of Science ®Google Scholar
  (g) G. Aridoss, S. Amirthaganesan, M. S. Kim, J. T. Kim, and Y. T. Jeong, “Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones,” Eur. J. Med. Chem. 44, (2009): 4199–210;
   PubMed Web of Science ®Google Scholar
  (h) D. N. Pansare, N. A. Mulla, C. D. Pawar, V. R. Shende, and D. B. Shinde, “One pot three components microwave assisted and conventional synthesis of new 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one as antimicrobial agents,” Bioorg. Med. Chem. Lett. 24, (2014): 3569–73;
   PubMed Web of Science ®Google Scholar
  (i) J. Wrobel, J. Jetter, W. Kao, J. Rogers, L. Di, J. Chi, M. C. Perez, G. C. Chen, and E. S. Shen, “5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists,” Bioorg. Med. Chem. 14, (2006): 5729–41;
   PubMed Web of Science ®Google Scholar
  (j) E. E. Carlson, J. F. May, and L. L. Kiessling, “Chemical Probes of UDP-Galactopyranose Mutase,” Chem. Biol. 13, (2006): 825;
   PubMed Web of Science ®Google Scholar
  (k) A. M. Panico, P. Vicini, A. Geronikaki, M. Incerti, V. Cardile, L. Crasci, R. Messina, and S. Ronsisvalle, “Heteroarylimino-4-thiazolidinones as inhibitors of cartilage degradation,” Bioorg. Chem. 39, (2011): 48–52;
   PubMed Web of Science ®Google Scholar
  (l) O. Mazzoni, A. M. di Bosco, P. Grieco, E. Novellino, A. Bertamino, F. Borrelli, R. Capasso, and M. V. Diurno, “Synthesis and Pharmacological Activity of 2‐(substituted)‐3‐{2‐[(4‐phenyl‐4‐cyano)piperidino]ethyl}‐1,3‐thiazolidin‐4‐ones,” Chem. Biol. Drug Des. 67, (2006): 432;
   PubMed Web of Science ®Google Scholar
  (m) Rahim F., T. Muhammad, H. Ullah, Wadood A., M. Selvaraj, A. Rab, Sajid M., Shah S. A. A., Uddin N., and Gollapalli M., “Synthesis of new arylhydrazide bearing Schiff bases/thiazolidinone: α-Amylase, urease activities and their molecular docking studies,” Bioorg. Chem. 91, (2019): 103112.
   PubMed Web of Science ®Google Scholar
• (a) M. Sala, A. Chimento, C. Saturnino, I. M. Gomez-Monterrey, S. Musella, A. Bertamino, C. Milite, M. S. Sinicropi, A. Caruso, R. Sirianni, P. Tortorella, E. Novellino, P. Campiglia, and V. Pezzi, “Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines,” Bioorg. Med. Chem. Lett. 23, (2013): 4990–95;
   PubMed Web of Science ®Google Scholar
  (b)J. Wu, L. Yu, F. Yang, J. Li, P. Wang, W. Zhou, L. Qin, Y. Li, J. Luo, Z. fang, M. Liu, and Y. M. Chen, “Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents,” Eur. Jour. of Med. Chem. 80, (2014): 340–51;
   PubMed Web of Science ®Google Scholar
  (c) N. S. Cutshall, C. O’Day, and M. Prezhdo, “Rhodanine derivatives as inhibitors of JSP-1,” Bioorg. Med. Chem. Lett. 15, (2005): 3374–79;
   PubMed Web of Science ®Google Scholar
  (d) R. Dayam, F. Aiello, J. Deng, Y. Wu, A. Garofalo, X. Chen, and N. Neamati, “Discovery of Small Molecule Integrin αvβ3 Antagonists as Novel Anticancer Agents,” J. Med. Chem. 49, (2006): 4526–34;
   PubMed Web of Science ®Google Scholar
  (e) K. S. S. Kumar, A. Hanumappa, M. Vetrivel, M. Hegde, Y. R. Girish, T. R. Byregowda, S. Rao, S. C. Raghavan, and K. S. Rangappa, “Antiproliferative and tumor inhibitory studies of 2,3 disubstituted 4-thiazolidinone derivatives,” Bioorg. Med. Chem. Lett. 25, (2015): 3616–20;
   PubMed Web of Science ®Google Scholar
  (f) R. Ottana, S. Carotti, R. Maccari, I. Landini, G. Chiricosta, B. Caciagli, M. G. Vigorita, and E. Mini, “In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones,” Bioorg. Med. Chem. Lett. 15, (2005): 3930–33;
   PubMed Web of Science ®Google Scholar
  (g) S. Chen, L. Chen, N. T. Le, C. Zhao, A. Sidduri, J. P. Lou, C. Michoud, L. Portland, N. Jackson, J. J. Liu, F. Konzelmann, F. Chi, C. Tovar, Q. Xiang, Y. Chen, Y. Wen, and L. T. Vassilev, “Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors,” Bioorg. Med. Chem. Lett. 17, (2007): 2134–38.
   PubMedGoogle Scholar
• Tihomir Tomašić, Roman Sink, Nace Zidar, Anja Fic, Carlos Contreras-Martel, Andréa Dessen, Delphine Patin, Didier Blanot, Manica Müller-Premru, Stanislav Gobec, et al. “Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus,” ACS Medicinal Chemistry Letters 3, no. 8 (2012): 626–30.
   PubMed Web of Science ®Google Scholar
• A. Bordessa, C. Colin-Cassin, V. Grillier-Vuissoz, S. Kuntz, S. Mazerbourg, G. Husson, M. Vo, S. Flament, H. Martin, Y. Chapleur, et al. “Optimization of Troglitazone Derivatives as Potent anti-Proliferative Agents: Towards More Active and Less Toxic Compounds,” European Journal of Medicinal Chemistry 83 (2014): 129–40.
   PubMed Web of Science ®Google Scholar
• L. Ma, H. Pei, L. Lei, L. He, J. Chen, X. Liang, A. Peng, H. Ye, M. Xiang, and L. Chen, “Structural Exploration, Synthesis and Pharmacological Evaluation of Novel 5-Benzylidenethiazolidine-2,4-Dione Derivatives as iNOS Inhibitors against Inflammatory Diseases,” European Journal of Medicinal Chemistry 92 (2015): 178–90.
   PubMed Web of Science ®Google Scholar
• S. Ponnuchamy, S. Kanchithalaivan, R. R. Kumar, M. Ashraf Ali, and T. S. Choon, “Antimycobacterial Evaluation of Novel Hybrid Arylidene Thiazolidine-2,4-Diones,” Bioorganic & Medicinal Chemistry Letters 24, no. 4 (2014): 1089–93.
   PubMed Web of Science ®Google Scholar
• V. R. Avupati, R. P. Yejella, A. Akula, G. S. Guntuku, B. R. Doddi, V. R. Vutla, S. R. Anagani, L. S. Adimulam, and A. K. Vyricharla, “Synthesis, Characterization and Biological Evaluation of Some Novel 2,4-Thiazolidinediones as Potential Cytotoxic, Antimicrobial and Antihyperglycemic Agents,” Bioorganic & Medicinal Chemistry Letters 22, no. 20 (2012): 6442–50.
   PubMed Web of Science ®Google Scholar
• G. Navarrete-Vazquez, H. Torres-Gomez, S. Hidalgo-Figueroa, J. J. Ramirez-Espinosa, S. Estrada-Soto, J. L. Medina-Franco, I. Leon-Rivera, F. J. Alarcon-Aguilar, and J. C. Almanza-Perez, “Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect,” Bioorganic and Medicinal Chemistry Letters 24 (2014): 4575–4579.
   PubMed Web of Science ®Google Scholar
• B. R. Bhattarai, B. Kafle, J. S. Hwang, S. W. Ham, K. H. Lee, H. Park, I. O. Han, and H. Cho, “Novel Thiazolidinedione Derivatives with anti-Obesity Effects: dual Action as PTP1B Inhibitors and PPAR-γ Activators,” Bioorganic & Medicinal Chemistry Letters 20, no. 22 (2010): 6758–63.
   PubMed Web of Science ®Google Scholar
• O. Bozdag-Dundar, O. Ozgen, A. Mentese, N. Altanlar, O. Atli, E. Kendi, and R. Ertan, “A new series of thiazolyl thiazolidine-2,4-diones were synthesized and tested for their in vitro antimicrobial activities,” Bioorganic and Medicinal Chemistry. 15, (2007): 6012–6017.
   PubMed Web of Science ®Google Scholar
• L. A. Dakin, M. H. Block, H. Chen, E. Code, J. E. Dowling, X. Feng, A. D. Ferguson, I. Green, A. W. Hird, T. Howard, et al. “Discovery of Novel Benzylidene-1,3-Thiazolidine-2,4-Diones as Potent and Selective Inhibitors of the PIM-1, PIM-2, and PIM-3 Protein Kinases,” Bioorganic & Medicinal Chemistry Letters 22, no. 14 (2012): 4599–604.
   PubMed Web of Science ®Google Scholar
• D. O. Bozdag, E. J. Verspohl, E. N. Das, R. M. Kaup, K. Bauer, M. Sarıkaya, B. Evranos, and R. Ertan, “A new series of flavonyl-2,4-thiazolidinediones were prepared by Knoevenagel reaction. The prepared compounds were tested for their aldose reductase inhibitory and insulinotropic activities”, Bioorganic and Medicinal Chemistry. 16, (2008): 6747–6751.
   PubMedGoogle Scholar
• Y. M. Ha, Y. J. Park, J. A. Kim, D. Park, J. Y. Park, H. J. Lee, J. Y. Lee, H. R. Moon, and H. Y. Chung, “Design and Synthesis of 5-(Substituted Benzylidene)Thiazolidine-2,4-Dione Derivatives as Novel Tyrosinase Inhibitors,” European Journal of Medicinal Chemistry 49 (2012): 245–52.
   PubMed Web of Science ®Google Scholar
• K. Liu, W. Rao, H. Parikh, Q. Li, T. L. Guo, S. Grant, G. E. Kellogg, and S. Zhang, “3,5-Disubstituted-Thiazolidine-2,4-Dione Analogs as Anticancer Agents: design, Synthesis and Biological Characterization,” European Journal of Medicinal Chemistry 47, no. 1 (2012): 125–37.
   PubMedGoogle Scholar
• R. Kallanagouda, and Alagawadi Alegaon, S.G, “Synthesis, characterization and antimicrobial activity evaluation of new 2,4-Thiazolidinediones bearing imidazo[2,1-b][1,3,4]thiadiazole moiety,” Arab. J. Chem 4, (2011): 465–472.
   Web of Science ®Google Scholar
• N. Zidar, T. Tomasic, R. Sink, A. Kovac, D. Patin, D. Blanot, C. Contreras-Martel, A. Dessen, M. M. Premru, A. Zega, et al. “New 5-Benzylidenethiazolidin-4-One Inhibitors of Bacterial MurD Ligase: design, Synthesis, Crystal Structures, and Biological Evaluation,” European Journal of Medicinal Chemistry 46, no. 11 (2011): 5512–23.
   PubMed Web of Science ®Google Scholar
• A. K. M. Iqbal, A. Y. Khan, M. B. Kalashetti, N. S. Belavagi, Y. D. Gong, and I. A. M. Khazi, European Journal of Medicinal Chemistry. 53, (2012): 308.
   PubMed Web of Science ®Google Scholar
• NCCLS. Method for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard; 5thed. DocumentM7-A5; NCCLS 2000; Wayne.
   Google Scholar
• X. He, A. M. Reeve, U. R. Desai, G. E. Kellogg, and K. A. Reynolds, “1,2-dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH),” Antimicrobial Agents and Chemotherapy 48, no. 8 (2004): 3093–102.
   PubMed Web of Science ®Google Scholar
• V. Vichai, and K. Kirtikara, “Sulforhodamine B Colorimetric Assay for Cytotoxicity Screening,” Nature Protocols 1, no. 3 (2006): 1112–6.
   PubMed Web of Science ®Google Scholar